CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Dr. Dmitriy Zamarin Answers Questions About Ovarian Cancer and Immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Dmitriy Zamarin, of Memorial Sloan Kettering Cancer Center, answers questions about immunotherapy clinical trials from the…

    December 14, 2021| CRI Staff
  • Gynecologic Cancer Awareness Month: 2021 Immunotherapy Research Updates

    This September for Gynecologic Cancer Awareness Month, we reflect on new treatments, research discoveries, and how CRI…

    September 3, 2021| Gabriella Rojas
  • Christine Sable

    Christine Sable’s Immunotherapy Story

    Ovarian Cancer |  Diagnosed 2003 Christine’s Story At age 44, Christine Sable had few worries about her cancer…
    April 27, 2021| CRI Staff
  • Dr. Kunle Odunsi Answers Questions About Ovarian Cancer and Immunotherapy From the 2020 CRI Virtual Immunotherapy Patient Summit

    Dr. Kunle Odunsi of Roswell Park Comprehensive Cancer Center answers questions about ovarian cancer and immunotherapy from…

    December 15, 2020| CRI Staff
  • Ovarian Cancer and Immunotherapy Breakout Session at the 2020 CRI Virtual Immunotherapy Patient Summit

    Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.

    November 23, 2020| Caroline Offit
  • Gynecologic Cancer Awareness Month: 2020 Immunotherapy Research Updates

    This September for Gynecologic Cancer Awareness Month, we look at new FDA approvals, new research, and how…

    September 10, 2020| CRI Staff
  • How Immunotherapy is Making an Impact in Gynecologic Cancers

    For Gynecologic Cancer Awareness Month, CRI spoke with Dr. Kunle Odunsi about immunotherapies for ovarian, cervical, and…

    September 8, 2020| Arthur N. Brodsky, PhD
  • Ovarian Cancer Awareness Month: 2019 Immunotherapy Research Update

    For Ovarian Cancer Awareness Month, we round up the latest news and research from the people changing…

    September 13, 2019| CRI Staff
  • How Immunotherapy Is Making an Impact in Ovarian Cancer

    We spoke with Dmitriy Zamarin, MD, PhD, about the current treatment landscape for patients with ovarian cancer,…

    September 12, 2019| Arthur N. Brodsky, PhD
1 2 3
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute